RADEK SKODA to Molecular Targeted Therapy
This is a "connection" page, showing publications RADEK SKODA has written about Molecular Targeted Therapy.
Connection Strength
0.030
-
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nat Commun. 2018 04 12; 9(1):1431.
Score: 0.030
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.